Keywords: sluggish cognitive tempo; attention-deficit/ hyperactivity disorder; methylphenidate; atomoxetine; treatment
Key Clinical Message: Although there is no proven evidence regarding pharmacotherapy of Sluggish Cognitive Tempo (SCT), we experienced that atomoxetine had much more effects in decreasing SCT symptoms compared to methylphenidate in a case with SCT and subthreshold ADHD.